The Global Type-2 Diabetes Market Analysis, 2020 market research report depicts a deep-dive market analysis of statistics of the Global Type-2 Diabetes market, which consists of regional and country-wise analysis of the market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market shares of various end users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “Global Type-2 Diabetes Market Analysis, 2020”, the market is anticipated to grow at a CAGR of around 8% during 2020-25 on account of the increasing prevalence of type 2 diabetes due to issues related to being overweight, physical inactiveness, and obesity. In addition, the rising geriatric population along with the surging population with type-1 diabetes and lack of proper healthcare infrastructure in the emerging countries is projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.
High Type-2 Diabetes Occurrence in Women
Based on gender, women hold a significant market share in the Global Type-2 Diabetes market 2019 owing to the rising prevalence of type-2 diabetes among pregnant women. Due to multiple adverse pregnancy outcomes, the development of gestational diabetes is high among pregnant women. In addition, the chance of developing type 2 diabetes is high, especially in three to six years after delivery. However, exposure to hyperglycemia in the womb affects the health of children resulting in overweight which make them more prone to developing type 2 diabetes in the coming years. Thus, it is projected to accentuate the market growth of type-2 diabetes in the forecasted period.
North America Segment Registered the Fastest Growth
North America captured a considerable market share in the Global Type-2 Diabetes market in 2019. The US acquired the majority market share in the region owing to the boost in the rate of obesity, cardiovascular, and chronic diseases in the country which has proliferated the growth of type-2 diabetes in people.
However, an astronomical growth in the number of type-2 diabetes is foreseen in the Asia-Pacific region. During the 21st century, it is projected that a large number of new diabetes cases would occur each year in the region due to the rising rate of obesity, increasing geriatric population, and poor-quality lifestyle of the people. The number of people with diabetes in Southeast Asia is 80 million in 2017 and is anticipated to surge to 151 million by the year 2045. Thus, these factors are projected to strongly contribute toward the growth of the Type-2 Diabetes market in the coming years as stated in the MarkNtel Advisors’ research report “Global Type-2 Diabetes Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Type-2 Diabetes market include Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson etc. To gain a competitive edge over the other market players, these companies are collaborating with other pharmaceutical firms for the launch of the products in other markets as well with an aim to have a strong foothold globally. Moreover, to make the diabetes digital health space less congested, the companies have entered the digital market by launching mobile health apps for the customer to ease them by keeping the track of their type 2 diabetes regimes.
Key Questions Answered in the Market Research Report
Market Outlook, Segmentation and Statistics
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global Type-2 Diabetes Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Million.
Q. What would be the growth rate or CAGR of Global Type-2 Diabetes Market during 2020-25?
A. The growth rate of Global Type-2 Diabetes Market during 2020-25 is forecast to be around 8%.
Q. Who are the key competitors or players operating in Global Type-2 Diabetes Market?
A. Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson etc., are few of the leading players in the Global Type-2 Diabetes Market.
Q. Which gender segment would emerge as an opportunity area for players in Global Type-2 Diabetes Market?
A. Women segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Type-2 Diabetes Market?
A. The North America grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for manufacturers and suppliers of Global Type-2 Diabetes Market.
